CHRISTINA METCALF: Open Payments
NPI 1063836542 · GREENWOOD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,599 in 119 payments from 17 companies in 2025. Trend: 2023 $1,115 · 2024 $2,409 · 2025 $2,599
Food & beverage: $2,599
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $578 |
| AstraZeneca Pharmaceuticals LP | 9 | $398 |
| PFIZER INC. | 22 | $374 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $241 |
| Amgen Inc. | 13 | $205 |
| Novo Nordisk Inc | 11 | $192 |
| SANOFI-AVENTIS U.S. LLC | 2 | $146 |
| Lilly USA, LLC | 11 | $122 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
Products named: VRAYLAR, AIRSUPRA, Kerendia, NURTEC ODT, QULIPTA, TZIELD, Ozempic, ZAVZPRET.
Industry payments across AR — which companies pay providers there.
